Marius, T. (2023). Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): A randomised, double-blind, placebo-controlled phase 3 trial. Springer.
Trích dẫn theo kiểu ChicagoMarius, Trøseid. Efficacy and Safety of Baricitinib in Hospitalized Adults With Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-blind, Placebo-controlled Phase 3 Trial. Springer, 2023.
Trích dẫn MLAMarius, Trøseid. Efficacy and Safety of Baricitinib in Hospitalized Adults With Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-blind, Placebo-controlled Phase 3 Trial. Springer, 2023.
Cảnh báo! Những trích dẫn này có thể không chính xác 100%.